Peptide YY in children: a review
1Department of Pediatrics, University of California, 500 Parnassus Ave MU 4E, San Francisco, CA 94134-0136, USA. wojcicki@gmail.com
Insights
Peptide YY (PYY) levels are higher in newborns than adults, with childhood PYY patterns becoming similar to adults as children age. Further research is needed on PYY
Area of Science:
- Pediatric Endocrinology
- Neuroscience
- Metabolic Research
Background:
- Peptide YY (PYY) is known to reduce food intake through the vagal-brainstem-hypothalamic pathway.
- Existing research suggests potential differences in PYY levels during early childhood compared to adult studies.
- A comprehensive synthesis of PYY studies in children has been lacking.
Purpose of the Study:
- To synthesize existing research on Peptide YY (PYY) levels in pediatric populations.
- To compare PYY levels and their associations in children versus adults.
- To identify knowledge gaps regarding PYY's role in child development and health.
Main Methods:
- Systematic review and synthesis of 21 relevant scientific articles.
- Inclusion of studies encompassing infants, newborns, primary school-aged children, and children with special health needs.
Main Results:
- Infants and newborns exhibit significantly higher PYY levels compared to older children and adults.
- The association between PYY levels, body composition, and obesity in children increasingly resembles adult patterns with age.
- Fasting PYY levels may be lower in obese children than adults, and weight loss might restore higher postprandial PYY levels, unlike in adults.
Conclusions:
- Further investigation is required to elucidate the significance of elevated PYY levels in infancy.
- Additional research should assess the impact of various dietary interventions on children's PYY levels across different developmental stages.
- Future studies should consider diverse racial and ethnic backgrounds when examining PYY's role in pediatric growth and development.
Background:
Peptide YY has been found to reduce food intake via the vagal-brainstem-hypothalamic pathway. There is some indication that PYY levels may differ in early childhood in comparison with adult studies. Studies of PYY in children have yet to be synthesized.
Methods:
This review synthesized 21 articles including studies with infants/newborns, primary school age children and populations with special health needs.
Results:
Some important differences emerge between studies of PYY in children in comparison to those with adults. In those studies with infants and newborns, there is a high level of PYY in preterm and full-term neonates in comparison with school age children and adults. As children get older the relationship between PYY levels and body composition and obesity is more similar to that of adults. Fasting PYY levels may be lower in obese children in comparison with adults and weight loss may restore a higher postprandial level of PYY in contrast with adults whose levels remain low.
Conclusions:
Additional studies are needed to better understand the role of higher PYY in infancy and to assess the effectiveness of different diets on children throughout time-points in growth and development as well as those with different racial/ethnic background.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Hormonal Regulation
Regulation of Food Intake
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:


